NGF and BDNF signaling control amyloidogenic route and Aβ production in hippocampal neurons
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Here, we report that interruption of NGF or BDNF signaling in hippocampal neurons rapidly activates the amyloidogenic pathway and causes neuronal apoptotic death. These events are associated with an early intracellular accumulation of PS1 N-terminal catalytic subunits and of APP C-terminal fragments and a progressive accumulation of intra- and extracellular Aβ aggregates partly released into the culture medium. The released pool of Aβ induces an increase of APP and PS1 holoprotein levels, creating a feed-forward toxic loop that might also cause the death of healthy neurons. These events are mimicked by exogenously added Aβ and are prevented by exposure to β- and γ-secretase inhibitors and by antibodies directed against Aβ peptides. The same cultured neurons deprived of serum die, but APP and PS1 overexpression does not occur, Aβ production is undetectable, and cell death is not inhibited by anti-Aβ antibodies, suggesting that hippocampal amyloidogenesis is not a simple consequence of an apoptotic trigger but is due to interruption of neurotrophic signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A study suggested that impaired BDNF nutritional signaling also stimulated the expression of APP and PS1 to exacerbate amyloidogenesis.352”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [352]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104 · cited 3×
“(2008) Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.”
BackgroundA phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
Tuszynski, M. H., Thal, L., Pay, M., Salmon, D. P., U, H. S., Bakay, R., Patel, P., Blesch, A., Vahlsing, H. L., Ho, G., et al. (2005) · Nature Medicine · doi:10.1038/nm1239 · Cited by 1,050 · cited 3×
“(2008) Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.”
BackgroundSalehi, A., Delcroix, J.-D., Belichenko, P. V., Zhan, K., Wu, C., Valletta, J. S., Takimoto-Kimura, R., Kleschevnikov, A. M., Sambamurti, K., Chung, P. P., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.022 · Cited by 543 · cited 3×
“(2008) Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.”
BackgroundThe role of neuronal growth factors in neurodegenerative disorders of the human brain
Connor, B., & Dragunow, M. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00004-6 · Cited by 536 · cited 3×
“(2008) Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.”
BackgroundNeurotrophic factors in Alzheimer’s and Parkinson’s disease brain
Siegel, G. J., & Chauhan, N. B. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00030-8 · Cited by 496
Cooper, J. D., Salehi, A., Delcroix, J.-D., Howe, C. L., Belichenko, P. V., Chua-Couzens, J., Kilbridge, J. F., Carlson, E. J., Epstein, C. J., & Mobley, W. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181219298 · Cited by 336 · cited 3×
“(2008) Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.”
BackgroundClinical relevance of the neurotrophins and their receptors
Allen, S. J., & Dawbarn, D. (2006) · Clinical Science · doi:10.1042/cs20050161 · Cited by 320 · cited 4×
“(2008) Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.”
BackgroundInfluentialAlzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 277
Rajagopal, R., Chen, Z.-Y., Lee, F. S., & Chao, M. V. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0010-04.2004 · Cited by 257 · cited 4×
“The presence of the active (pTrKA) receptor in hippocampal neurons incubated with ( NGF) or without NGF ( NGF) for 48 h was verified by Western blot analysis using selective anti-popsho TrKA antibody kindly provided by M. Chao (New York University, New York) (22).”
BackgroundInfluentialβ-Amyloid1–42Induces Neuronal Death through the p75 Neurotrophin Receptor
Sotthibundhu, A., Sykes, A. M., Fox, B., Underwood, C. K., Thangnipon, W., & Coulson, E. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0350-08.2008 · Cited by 236 · cited 3×
“(2008) Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.”
Background
Cited by
Items 101–175 of 175
Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice
Kapadia, M., Mian, M. F., Michalski, B., Azam, A. B., Ma, D., Salwierz, P., Christopher, A., Rosa, E., Zovkic, I. B., Forsythe, P., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-170779 · Cited by 29
“The early loss of BDNF expression in 3xTg-AD mice is associated with higher levels of soluble Aβ species in the absence of tau pathology, suggesting neurotrophic deficits in this strain are a consequence of Aβ accumulation [31, 32] or alternatively, a driver of Aβ pathology [65, 66].”
Harnessing BDNF Signaling to Promote Resilience in Aging
Faraji, J., & Metz, G. A. S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0961 · Cited by 29
Kelliny, S., Zhou, X., & Bobrovskaya, L. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70046 · Cited by 30
“Interruption of NGF and BDNF signaling activates amyloidogenesis and favors apoptotic cell death via proNGF/p75 NTR signaling in hippocampal neurons (Matrone et al. 2008; Pedraza et al. 2005).”
Jung, S., Nah, J., Han, J., Choi, S.-G., Kim, H., Park, J., Pyo, H.-K., & Jung, Y. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13597 · Cited by 28
“2009) and causes ROS generation, leading to cytotoxic damage (Matrone et al. 2008).”
BackgroundLauzon, M.-A., Drevelle, O., & Faucheux, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-04835-x · Cited by 27
Martínez‐Cué, C., & Rueda, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186906 · Cited by 26
“Dysfunction of NGF signalling induces the accumulation of APP C-terminal fragments and Aβ aggregation [100].”
BackgroundCross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases
Loch, R. A., Wang, H., Perálvarez‐Marín, A., Berger, P., Nielsen, H. M., Chroni, A., & Luo, J. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.01.022 · Cited by 26
“The interruption of BDNF signaling in hippocampal neurons was found to rapidly activate the amyloidogenic pathway for Aβ production, causing neuronal apoptotic death [53].”
BackgroundOnyango, I. G., Ahn, J., Tuttle, J. B., Bennett Jr, J. P., & Swerdlow, R. H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06871.x · Cited by 25
Joshi, R., & Salton, S. R. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.932497 · Cited by 27
Matrone, C., Iannuzzi, F., & Annunziato, L. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.04.003 · Cited by 25
Self-citationMatrone, C. (2013) · BioEssays · doi:10.1002/bies.201300041 · Cited by 25
“This relevant crosstalk between NGF and APP fits into a more complex scenario in which an imbalance in NGF/proNGF levels and an alteration in NGF receptor signaling appear to be strictly related to amyloidogenic processing of APP, Ab accumulation, and neuronal decline [34–39].”
BackgroundSelf-citationLim, J. Y., Reighard, C., & Crowther, D. C. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv130 · Cited by 25
“There is some evidence that that Aβ may reduce TrkB-mediated neurotrophic signaling (16); conversely, a reduction in BDNF may favor the amyloidogenic processing of the amyloid precursor protein, favouring Aβ generation (17).”
BackgroundKeller, N., Christensen, T. A., Wanberg, E. J., Salisbury, J. L., & Trushina, E. V. (2025) · Scientific Reports · doi:10.1038/s41598-025-90925-0 · Cited by 23
“In APP/PS1 mice, levels of post-synaptic protein PSD95, brain derived neurotrophic factor (BDNF) essential for neuronal function and survival 45 , and mitochondria specific deacetylase Sirtuin 3 (Sirt3) that is required for synaptic and neuronal functions 46 were significantly reduced compared to…”
Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease
Matrone, C., Dzamko, N. L., Madsen, P., Nyegaard, M., Pohlmann, R., Søndergaard, R. V., Lassen, L. B., Andresen, T. L., Halliday, G. M., Jensen, P. H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160501 · Cited by 24
“Cortical neurons were prepared from embryonic day 17/18 (E17/E18) mice, as previously reported [26].”
MethodSelf-citationControl of Aβ release from human neurons by differentiation status and RET signaling
Scholz, D., Chernyshova, Y., & Leist, M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.012 · Cited by 22
Turnbull, M. T., Boskovic, Z., & Coulson, E. J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00051 · Cited by 24
“In vitro, Matrone et al. (2008) demonstrated that complete withdrawal of BDNF from hippocampal neurons using a blocking antibody resulted in increased Aβ production.”
BackgroundFrom understanding synaptic plasticity to the development of cognitive enhancers
Cheung, Z. H., & Ip, N. Y. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001537 · Cited by 22
“Interestingly, it was recently demonstrated that BDNF deprivation enhances Ab generation in hippocampal neurons (Matrone et al. 2008).”
BackgroundSORLA/SORL1, a neuronal sorting receptor implicated in Alzheimer’s disease
Willnow, T. E., Carlo, A.-S., Rohe, M., & Schmidt, V. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.4.315 · Cited by 20
Sirt‐1 Regulates Physiological Process and Exerts Protective Effects against Oxidative Stress
Liu, L., Xia, G., Li, P., Wang, Y., & Zhao, Q. L. (2021) · BioMed Research International · doi:10.1155/2021/5542545 · Cited by 21
“Previous literature studies have shown that Sirt-1 regulates the transcriptional regulatory activity of p53 by deacetylation of p53, which is similar to our results [20].”
ResultTriaca, V., Ruberti, F., & Canu, N. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-74046-7_10 · Cited by 20
Xu, Y., Wang, D., Luo, Y., Li, W., Ye, S., Tan, X., & Zhu, C. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.027 · Cited by 20
Erratum: Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity
Scarpi, D., Cirelli, D., Matrone, C., Castronovo, G., Rosini, P., Occhiato, E. G., Romano, F., Bartali, L., Clemente, A. M., Bottegoni, G., et al. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.129 · Cited by 19
“characterized rat hippocampal neuronal model, in which NGF deficit is strictly connected to the activation of the amyloidogenic pathway.(7,20) In this neuronal in vitro model, accumulation of both amyloid precursor protein (APP) and”
BackgroundMethodSelf-citationCapsoni, S., Arisi, I., Malerba, F., D’Onofrio, M., Cattaneo, A., & Cherubini, E. (2022) · Brain Sciences · doi:10.3390/brainsci12060783 · Cited by 18
“Further direct links between NGF deficits and the activation of the AD amyloidogenic pathway have been demonstrated in cultured hippocampal neurons [90].”
BackgroundSERP1 is an assembly regulator of γ-secretase in metabolic stress conditions
Jung, S., Hyun, J., Nah, J., Han, J., Kim, S.-H., Park, J., Oh, Y., Gwon, Y., Moon, S., Jo, D., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aax8949 · Cited by 17
Pitsikas, N., & Gravanis, A. (2017) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2017.03.004 · Cited by 17
Jiao, F., Jiang, D., Li, Y., Mei, J., Wang, Q., & Li, X. (2022) · Cells · doi:10.3390/cells11203201 · Cited by 17
“In fact, the signaling pathway of NTFs can regulate amyloidogenesis [17,18], and proteins in the amyloidogenic process pathway affect the NTF signaling pathways [19,20].”
BackgroundXie, H., Xiao, Z., & Huang, J. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0690-7 · Cited by 15
Neurotrophic factor alpha 1 gene therapy in Alzheimer’s disease: scope and advancements
Shaikh, A., Ahmad, F., Teoh, S. L., Kumar, J., & Yahaya, M. F. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1518868 · Cited by 13
Neurobiological and therapeutic landmarks of depression associated with Alzheimer’s disease dementia
Untu, I., Davidson, M., Stanciu, G. D., Rabinowitz, J., Dobrin, R., Vieru, D. S., & Tamba, B.-I. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1584607 · Cited by 17
Khashali, H. A., Ray, R., Coleman, K.-L., Atali, S., Haddad, B., Wareham, J., Guthrie, J. W., Heyl, D., & Evans, H. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810746 · Cited by 13
Xiong, F., Xiao, B.-L., Wang, Q., Liu, K., Wu, H.-W., Jing, C., Tong, K.-N., Zhang, Z., & Guo, W. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01333-z · Cited by 12
“…the normal interaction between APP and TrkA by disrupting APP phosphorylation at Thr668 in hippocampal neurons to prevent pathological Aβ aggregation and the overaction of proapoptotic factors, e.g., Bcl-2-modify-ing factor (Bmf) (Akhter et al. 2018; Triaca et al. 2016; Matrone et al. 2008).”
Sunkaria, A., Yadav, A., Bhardwaj, S., & Sandhir, R. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.10.021 · Cited by 14
“It has been shown that increased pro:mature Bdnf ratio could mediate defective processing of amyloid precursor protein which promote Aβ aggregation (Matrone et al., 2008).”
Januário, Y. C., Eden, J., de Oliveira, L. S., Pace, R. D., Tavares, L., da Silva-Januário, M. E., Apolloni, V. B., Wilby, E. L., Altmeyer, R., Burgos, P. V., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102172 · Cited by 12
Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity
Petrella, C., Ciotti, M. T., Nisticò, R., Piccinin, S., Calissano, P., Capsoni, S., Mercanti, D., Cavallaro, S., Possenti, R., & Severini, C. (2020) · Cells · doi:10.3390/cells9122651 · Cited by 12
“Numerous papers have proposed NGF as a possible therapeutic option in the treatment of Alzheimer’s disease (AD) due to its ability to sustain cholinergic activity [2–4] and its neuroprotective function [5,6], together with its ability to directly inhibit amyloidogenesis [7,8].”
BackgroundSelf-citationA Review of Brain-Targeted Nonviral Gene-Based Therapies for the Treatment of Alzheimer’s Disease
Arora, S., Sharma, D., Layek, B., & Singh, J. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00611 · Cited by 12
Reduced levels of NGF shift astrocytes toward a neurotoxic phenotype
Tiberi, A., Carucci, N. M., Testa, G., Rizzi, C., Pacifico, P., Borgonovo, G., Arisi, I., D’Onofrio, M., Brandi, R., Gan, W., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1165125 · Cited by 10
“It has been previously reported that treatment of NGF in hippocampal neurons leads to rapid activation of the amyloidogenic pathway and causes neuronal apoptotic death (Matrone et al., 2008).”
BackgroundLin, L.-F., Liao, M., Xue, X., Zhang, W., Yan, L., Cai, L., Zhou, X., Zhou, X., & Luo, H. (2012) · Neuroscience Bulletin · doi:10.1007/s12264-012-1287-6 · Cited by 11
“[66] Matrone C, Ciotti MT, Mercanti D, Marolda R, Calissano P.”
BackgroundMagrì, A. L., Mendola, D. L., & Rizzarelli, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105085 · Cited by 11
Prevost, R., Chrétien, B., Minoc, E.-M., Dolladille, C., Silva, A. D., Nehme, A., Joly, F., Lelong‐Boulouard, V., & Bastien, E. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1278682 · Cited by 9
“In in vitro , BDNF/TRK deprivation is associated with elevations of the β - amyloid peptide in hippocampal neurons, leading to apoptotic death (Matrone et al., 2008).”
BackgroundMagrì, A. L., Tomasello, B., Николаевна, Н. И., Tabbì, G., Cairns, W. R. L., Greco, V., Sciuto, S., Mendola, D. L., & Rizzarelli, E. (2024) · Biomolecules · doi:10.3390/biom14091104 · Cited by 10
Computational prediction and analysis of the DR6–NAPP interaction
Ponomarev, S. Y., & Audie, J. (2010) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22962 · Cited by 9
Neta, F. I., de Souza, F. E. S., Batista, A. L., Pinheiro, F. I., Cobucci, R. N., & Gúzen, F. P. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220318092003 · Cited by 9
Lee, H.-R., Hwang, I.-S., Kim, J., Choi, S., Lee, Y.-J., Goo, J.-S., Lee, E.-P., Choi, H.-W., Kim, H.-S., Lee, J., et al. (2012) · Laboratory Animal Research · doi:10.5625/lar.2012.28.2.109 · Cited by 10
“neurons [7].”
Basic approach on the protective effects of hesperidin and naringin in Alzheimer’s disease
Kuşi, M., Becer, E., & Vatansever, S. (2024) · Nutritional Neuroscience · doi:10.1080/1028415x.2024.2397136 · Cited by 8
Faraji, J., & Metz, G. A. S. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.73 · Cited by 9
“114,115 BDNF and OT co ‐ expression likewise refers to the simultaneous production and correlated presence of both BDNF and OT, when neurons or other relevant cells are capable of synthesizing and releasing both molecules, thus enabling integrated signaling.”
Elsworthy, R. J., Dunleavy, C., Whitham, M., & Aldred, S. (2022) · Aging and Health Research · doi:10.1016/j.ahr.2022.100093 · Cited by 9
Liu, H., Han, L., Xia, X., & Xiang, X. (2022) · Oil Crop Science · doi:10.1016/j.ocsci.2022.02.008 · Cited by 8
EPIGENETIC MECHANISMS IN ALZHEIMER'S DISEASE: STATE-OF-THE-ART
Faltraco, F., Lista, S., Garaci, F., & Hampel, H. (2012) · Cineca Institutional Research Information System (Tor Vergata University) · Cited by 5
Petkova-Kirova, P. S., Anastassova, N., Minchev, B., Uzunova, D. N., Grigorova, V., Tsvetanova, E. R., Georgieva, A. P., Alexandrova, A., Stefanova, M. O., Yancheva, D. Y., et al. (2024) · Molecules · doi:10.3390/molecules29235711 · Cited by 5
“…and exerting protective effects against A β -induced toxicity [111–114], whereas the interruption of BDNF signaling in hippocampal neurons activates the amyloidogenic pathway, accompanied by progressive accumulation of intra-and extracellular A β aggregates, and neuronal apoptotic death [115].”
Toledano‐Díaz, A., Álvarez, M. I., & Tolédano, A. (2022) · Journal of Central Nervous System Disease · doi:10.1177/11795735221123896 · Cited by 5
Zhang, S., Gu, X. F., Zhang, M., Ding, N., Yang, J., & Wang, T. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261418553 · Cited by 4
“BDNF downregulation also weakens BDNF signaling, 61 which activates the JAK2/STAT3 and C/EBP β pathways while deacti-vating the Akt signal protein, 62,63 thereby activating AEP (or δ -secretase) and thus amyloid-β protein precursor (A β PP) and tau protein cleavage.”
Ouerdane, Y., El-Nahas, Z. S., Ouerdane, F., Hamam, K. M., & Ebada, M. A. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_12 · Cited by 4
Maino, B., Spampinato, A. G., Severini, C., Petrella, C., Ciotti, M. T., D’Agata, V., Calissano, P., & Cavallaro, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26744 · Cited by 3
Self-citationAvers, D., & Williams, A. K. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-02948-3.00017-1 · Cited by 3
Dewey, C. W., & Brunke, M. W. (2025) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.25.09.0578 · Cited by 2
BDNF alters β-cleavage of APP and subcellular distribution of BACE1
Hallam, R. D., Foran, G., Fletcher, N. K., MacPherson, R. E. K., & Necakov, A. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00642.2025 · Cited by 2
A new lens on Alzheimer's disease: Insights into the Edinger-Westphal nucleus and its circuits
Zhou, Y., Su, T., Yuan, M., Li, W., Zhou, Y., Kou, J., Chang, J.-S., Liu, D., Chen, L., Zhan, K., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251372587 · Cited by 1
Ciric, J., Perović, M., Milovanovic, N., Polaka, S., Macura, I. J., Nestorović, N. M., & Tešić, V. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05355-w · Cited by 2
“In contrast, BDNF supplementation reduces the generation of toxic Aβ [58] and restores learning and memory deficits [59].”
Chaulagain, B., Gothwal, A., Mahanta, A. K., Jarajapu, Y. P. R., & Singh, J. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c01009 · Cited by 1
Inflammatory proteins and cognitive decline in older Black adults
Meir, A. Y., Adeola, H. A., Tasaki, S., Liang, L., Robinson, R. A. S., Capuano, A. W., & Barnes, L. L. (2026) · Brain · doi:10.1093/brain/awag246 · Cited by 1
A possible physiological role of Abeta as a crosslinker
Blöchl, R. (2008)
Audie, J., & Ponomarev, S. Y. (2010) · Nature Precedings · doi:10.1038/npre.2010.4545.1
“Recently, Nikolaev and co-workers described a protein-protein interaction between death cell receptor 6 (DR6), a transmembrane protein that is a member of the Tumor Necrosis Factor (TNF) family of proteins, and the N-terminal domain (1-286) of amyloid precursor protein (NAPP).”
BackgroundDetermining the Role of Trib3 in Neuronal Apoptosis
Zareen, N. (2012) · doi:10.7916/d8tf04gw
Johnson, M. (2012) · Materials and Methods · doi:10.13070/mm.fr.2.113
Johnson, M. (2012) · 实验材料和方法 · doi:10.13070/mm.cn.2.113
Neuroprotection induced by neurotrophic factors
Réus, G. Z., Manosso, L. M., Botelho, M. E. M., Arent, C. O., Pedro, L. C., & Quevedo, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00063-4
Gries, M., Puhl, H. R., Schulte, S., Christmann, A., Rommel, S., Baller, M. K., Martin, M., Hartmann, T., Grimm, M. O. W., & Schäfer, K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.26.678722
“Furthermore, Aβ reduces the expression of neurotrophins such as BDNF and NGF, which are essential for neurite outgrowth(Matrone et al , 2008).”
Xu, D. C., Sas‐Nowosielska, H., Donahue, G., Huang, H., Pourshafie, N., Good, C. R., & Berger, S. L. (2024) · Figshare · doi:10.6084/m9.figshare.26658526
Xu, D. C., Sas‐Nowosielska, H., Donahue, G., Huang, H., Pourshafie, N., Good, C. R., & Berger, S. L. (2024) · Figshare · doi:10.6084/m9.figshare.26658529
ANIMAL Antidépresseurs, neuroinflammation et maladie d'alzheimer
Gosselin, T. (2016) · theses.fr (ABES) · doi:10.70675/11bcd9acz165fz4338zb013z5a469c5aed72
Fan, D., Wang, Y., Han, J., Liu, H., Zhu, Z., Hu, Z., Tao, H., Li, Y., & Shen, Z. (2026) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2026.103035
Dixon, E. K., Azimian, F., Joby-Chacko, A., Tatum, R., Boykin, C., Chen, Y., & Lu, Q. (2026) · Scientific Reports · doi:10.1038/s41598-026-72708-3
Validation of p75ECD and Edaravone as neuroprotective drug candidates for neurodegenerative diseases
Kelliny, S. (2021) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Metadata
- Authors
- Matrone, C., Ciotti, M. T., Mercanti, D., Marolda, R., & Calissano, P.
- Affiliations
- Institute of Neurobiology and Molecular Medicine (IT)
- Corresponding author
- Calissano, Pietro
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-09-02
- Volume
- 105
- Issue
- 35
- Pages
- 13139-13144
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2525562
- OpenAlex
- W2103126447
- Cited by
- 169
- References
- 24
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 9 · 2023: 6 · 2022: 17 · 2021: 13 · 2020: 8 · 2019: 10 · 2018: 7 · 2017: 9 · 2016: 7 · 2015: 7 · 2014: 9 · 2013: 5 · 2012: 16
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Regione Lazio
- National Institute on Aging (R01AG025970)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- nerve growth factor, brain-derived neurotrophic factor, neurotrophic signaling, amyloidogenic pathway, amyloid-beta production, hippocampal neurons, neuronal apoptosis, presenilin 1, APP C-terminal fragments, beta-secretase inhibitors, gamma-secretase inhibitors, Alzheimer's disease
- MeSH terms
- Animals, Antibodies, Cell Extracts, Cell Nucleus, Enzyme Inhibitors, Female, Hippocampus, Neurons, Pregnancy, Blotting, Western, Signal Transduction, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Cell Death, Rats, Wistar, Brain-Derived Neurotrophic Factor, Nerve Growth Factor, Serum, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.